Lactobacillus rhamnosus R0343ND and Reduced Incidence of Respiratory Illness

• Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial

  • 2012-06-13
  • RCT · n = 523
  • European Journal of Clinical Nutrition 66(9)
  • • M. Kumpu
    • R. Kekkonen
    • Hannu J. Kautiainen
    • S. Järvenpää
    • A. Kristo
    • P. Huovinen
    • A. Pitkäranta
    • R. Korpela
    • K. Hatakka

  • PubMed: 22692023
  • DOI: 10.1038/ejcn.2012.62

  2 Insights on

  • Reduced Incidence of Respiratory Illness

  • High evidence
  • Large Human Trial
  • Highly Cited
  • Rigorous Journal
  • Children

  Number of days with at least one respiratory symptom in all subjects was 5.03/month (95% confidence interval (CI): 4.92-5.15) in the GG group and 5.17/month (95% CI: 5.05-5.29) in the placebo group incidence rate ratio (IRR) 0.97; 95% CI: 0.94-1.00; P=0.098).

  Effect

  Neutral

  Effect size

  Small

  Significant

  No